Active Ingredient(s): Tavaborole
FDA Approved: * July 7, 2014
Pharm Company: * ANACOR PHARMS INC
Category: Antifungal

Tavaborole, sold under the brand name Kerydin, is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed. Tavaborole was approved by the US FDA in July 2014.[1] The medication inhibits an essential fungal enzyme, leucyl-tRNA synthetase, that is required for protein synthesis. The inhibition of protein synthesis leads to termination of cell growth and then cell death, eliminating the fungal infection. Contents 1 Medical... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Kerydin 43.5 mg/ml Topical Solution
NDC: 10337-905
Pharmaderm, a Division of Fougera Pharmaceuticals Inc.
Kerydin 43.5 mg/ml Topical Solution
NDC: 55724-111
Anacor Pharmaceuticals, Inc